高级检索
王祖定, 邓兰, 徐鸣夏. 双哌嗪类化合物的合成及钙通道阻滞活性[J]. 中国药科大学学报, 2011, 42(6): 503-506.
引用本文: 王祖定, 邓兰, 徐鸣夏. 双哌嗪类化合物的合成及钙通道阻滞活性[J]. 中国药科大学学报, 2011, 42(6): 503-506.
WANG Zu-ding, DENG Lan, XU Ming-xia. Synthesis and calcium channel blocking activities of dipiperazine compounds[J]. Journal of China Pharmaceutical University, 2011, 42(6): 503-506.
Citation: WANG Zu-ding, DENG Lan, XU Ming-xia. Synthesis and calcium channel blocking activities of dipiperazine compounds[J]. Journal of China Pharmaceutical University, 2011, 42(6): 503-506.

双哌嗪类化合物的合成及钙通道阻滞活性

Synthesis and calcium channel blocking activities of dipiperazine compounds

  • 摘要: 为寻求活性更好、毒性更低的新结构类型钙通道阻滞剂,以氟桂利嗪为先导化合物,设计合成了一系列双哌嗪类新化合物,并经光谱证明其结构。初步药理实验结果表明,9个新化合物在45Ca2+跨膜内流动药理实验中,对大鼠主动脉电压依赖型钙离子通道(PDC)均有钙阻滞活性,且部分化合物的活性强于阳性对照药硝苯吡啶。

     

    Abstract: With using flunarizine as a lead compund to search for calcium channel blockers with fewer side effects and improved potency,a series of dipiperazine compounds were prepared with their structures being confirmed by spectrometry.Their inhibitory effect on potential-dependent calcium channels(PDC) and Ca2+ antagonistic effect in rat aorta were determined by 45Ca2+ transmembrane influx technique.Preliminary results showed that all the nine new compounds possessed calcium channel blocking activities.Some compounds exhibited stronger inhibitory effect on PDC than nifedipine.

     

/

返回文章
返回